IDH2 and neoplasm: This is compounded by CDKN2A/B homozygous deletion being known to occur in only a minority of IDH-mutant astrocytomas — about 0–12% of histological grade 2 tumours and 6–20% of grade 3 [19, 20, 33, 34].